E. GERALD KAY - 09 Nov 2022 Form 4 Insider Report for INTEGRATED BIOPHARMA INC (INBP)

Role
Executive Chairman & President, Director, 10%+ Owner
Signature
/s/ E. Gerald Kay
Issuer symbol
INBP
Transactions as of
09 Nov 2022
Net transactions value
$0
Form type
4
Filing time
10 Nov 2022, 17:39:23 UTC
Previous filing
11 May 2022
Next filing
16 Nov 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INBP Stock Option (right to buy) Award $0 +100,000 $0.000000 100,000 09 Nov 2022 Common Stock 100,000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Exercise Price of the Stock Option will be 110% the closing prices of the Issuer's Common Stock on the fifth trading day after the filing of the Issuer's Quarterly Report on Form 10-Q for the period ended September 30, 2022, with the Securities and Exchange Commission.
F2 The option vests and becomes exercisable in three equal annual installments with the first installment vesting on November 9, 2023.